Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam vs dexmedetomidine as premedication for pediatric dental anxiety
IRCT201601281882N7Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of midazolam and dexmedetomidine in anxiety disorder and Procedural anxiety (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Children behavior during dental treatment and Anxiety level. Started Feb 2016; status: completed.
02
Drugs
midazolamdexmedetomidine
03
Conditions
anxiety disorderProcedural anxiety
Beyond the preview
Go deeper on IRCT201601281882N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201601281882N7.